DK183583D0 - Fremgangsmade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner - Google Patents

Fremgangsmade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner

Info

Publication number: DK183583D0
Authority: DK; Denmark
Prior art keywords: benzoazacycloalkyl; imidazolidines; spiro; preparing; preparing benzoazacycloalkyl
Prior art date: 1982-04-27

Application number

DK1835/83A

Other languages

English (en)

Other versions

DK183583A (da

Inventor

Charles Malen

Jean-Louis Peglion

Jacques Duhault

Michelle Boulanger

Original Assignee

Adir

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-04-27

Filing date

1983-04-26

Publication date

1983-04-26

1983-04-26 Application filed by Adir filed Critical Adir

1983-04-26 Publication of DK183583D0 publication Critical patent/DK183583D0/da

1983-10-28 Publication of DK183583A publication Critical patent/DK183583A/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Diabetes (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Ophthalmology & Optometry (AREA)
Endocrinology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

DK183583A 1982-04-27 1983-04-26 Fremgangsmaade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner DK183583A (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR8207203		1982-04-27
FR8207203A FR2525603A1 (fr)	1982-04-27	1982-04-27	Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique

Publications (2)

Publication Number	Publication Date
DK183583D0 true DK183583D0 (da)	1983-04-26
DK183583A DK183583A (da)	1983-10-28

Family

ID=9273425

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK183583A DK183583A (da)	1982-04-27	1983-04-26	Fremgangsmaade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner

Country Status (22)

Country	Link
JP (1)	JPS5910584A (da)
KR (1)	KR840004428A (da)
AT (1)	ATA125383A (da)
AU (1)	AU1395383A (da)
BE (1)	BE896572A (da)
DD (1)	DD209833A5 (da)
DE (1)	DE3315106A1 (da)
DK (1)	DK183583A (da)
ES (1)	ES8405796A1 (da)
FR (1)	FR2525603A1 (da)
GB (1)	GB2133401B (da)
GR (1)	GR78481B (da)
IL (1)	IL68497A0 (da)
IT (1)	IT1167123B (da)
LU (1)	LU84770A1 (da)
MA (1)	MA19783A1 (da)
NL (1)	NL8301476A (da)
NO (1)	NO831473L (da)
OA (1)	OA07412A (da)
PT (1)	PT76595B (da)
SE (1)	SE8302347L (da)
ZA (1)	ZA832927B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4927831A (en) *	1988-10-20	1990-05-22	American Home Products	Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
AU617541B2 (en) *	1988-10-20	1991-11-28	Wyeth	Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US6953787B2 (en)	2002-04-12	2005-10-11	Arena Pharmaceuticals, Inc.	5HT2C receptor modulators
EP2332919A3 (en)	2003-06-17	2011-10-19	Arena Pharmaceuticals, Inc.	Processes for preparing 3-benzazepines
US7704993B2 (en)	2003-06-17	2010-04-27	Arena Pharmaceuticals, Inc.	Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
CN102321023A (zh)	2004-12-21	2012-01-18	艾尼纳制药公司	(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓盐酸盐的晶型
AU2005322183B2 (en)	2004-12-23	2012-03-29	Arena Pharmaceuticals, Inc.	5HT2C receptor modulator compositions and methods of use
EP2001852A2 (en)	2006-04-03	2008-12-17	Arena Pharmaceuticals, Inc.	Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
US8299241B2 (en)	2006-12-05	2012-10-30	Arena Pharmaceuticals, Inc.	Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof
WO2009111004A1 (en)	2008-03-04	2009-09-11	Arena Pharmaceuticals, Inc.	Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
CN102648170A (zh)	2009-06-18	2012-08-22	艾尼纳制药公司	制备5-ht2c受体激动剂的方法
US9045431B2 (en)	2010-06-02	2015-06-02	Arena Pharmaceuticals, Inc.	Processes for the preparation of 5-HT2C receptor agonists
AU2011296014A1 (en)	2010-09-01	2013-04-04	Arena Pharmaceuticals, Inc.	Salts of lorcaserin with optically active acids
EP3485878A1 (en)	2010-09-01	2019-05-22	Arena Pharmaceuticals, Inc.	Modified-release dosage forms of 5-ht2c agonists useful for weight management
US9365521B2 (en)	2010-09-01	2016-06-14	Arena Pharmaceuticals, Inc.	Non-hygroscopic salts of 5-HT2C agonists
NZ608266A (en)	2010-09-01	2015-09-25	Arena Pharm Inc	Administration of lorcaserin to individuals with renal impairment
JP2015534563A (ja)	2012-10-09	2015-12-03	アリーナファーマシューティカルズ，インコーポレイテッド	体重管理の方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4209630A (en) *	1976-10-18	1980-06-24	Pfizer Inc.	Hydantoin derivatives as therapeutic agents
US4235911A (en) *	1979-06-13	1980-11-25	Pfizer Inc.	Hydantoin derivatives

1982
- 1982-04-27 FR FR8207203A patent/FR2525603A1/fr active Granted
1983
- 1983-04-08 AT AT0125383A patent/ATA125383A/de not_active IP Right Cessation
- 1983-04-25 DD DD83250187A patent/DD209833A5/de unknown
- 1983-04-25 LU LU84770A patent/LU84770A1/fr unknown
- 1983-04-26 NL NL8301476A patent/NL8301476A/nl not_active Application Discontinuation
- 1983-04-26 IT IT48155/83A patent/IT1167123B/it active
- 1983-04-26 IL IL68497A patent/IL68497A0/xx unknown
- 1983-04-26 ZA ZA832927A patent/ZA832927B/xx unknown
- 1983-04-26 PT PT76595A patent/PT76595B/pt unknown
- 1983-04-26 NO NO831473A patent/NO831473L/no unknown
- 1983-04-26 AU AU13953/83A patent/AU1395383A/en not_active Abandoned
- 1983-04-26 JP JP58073687A patent/JPS5910584A/ja active Pending
- 1983-04-26 GR GR71214A patent/GR78481B/el unknown
- 1983-04-26 BE BE0/210633A patent/BE896572A/fr not_active IP Right Cessation
- 1983-04-26 SE SE8302347A patent/SE8302347L/xx not_active Application Discontinuation
- 1983-04-26 KR KR1019830001753A patent/KR840004428A/ko not_active Withdrawn
- 1983-04-26 DK DK183583A patent/DK183583A/da not_active Application Discontinuation
- 1983-04-27 MA MA20003A patent/MA19783A1/fr unknown
- 1983-04-27 ES ES521895A patent/ES8405796A1/es not_active Expired
- 1983-04-27 GB GB08311508A patent/GB2133401B/en not_active Expired
- 1983-04-27 DE DE19833315106 patent/DE3315106A1/de not_active Withdrawn
- 1983-04-27 OA OA57984A patent/OA07412A/xx unknown

Also Published As

Publication number	Publication date
PT76595B (fr)	1986-01-21
AU1395383A (en)	1983-11-03
SE8302347L (sv)	1983-10-28
IT1167123B (it)	1987-05-13
DK183583A (da)	1983-10-28
ATA125383A (de)	1986-05-15
NL8301476A (nl)	1983-11-16
OA07412A (fr)	1984-11-30
KR840004428A (ko)	1984-10-15
MA19783A1 (fr)	1983-12-31
DD209833A5 (de)	1984-05-23
BE896572A (fr)	1983-10-26
GB8311508D0 (en)	1983-06-02
NO831473L (no)	1983-10-28
JPS5910584A (ja)	1984-01-20
ZA832927B (en)	1984-06-27
GB2133401B (en)	1985-10-23
ES521895A0 (es)	1984-06-16
FR2525603A1 (fr)	1983-10-28
ES8405796A1 (es)	1984-06-16
DE3315106A1 (de)	1983-11-03
PT76595A (fr)	1983-05-01
SE8302347D0 (sv)	1983-04-26
GR78481B (da)	1984-09-27
GB2133401A (en)	1984-07-25
IT8348155A0 (it)	1983-04-26
FR2525603B1 (da)	1984-09-14
IL68497A0 (en)	1983-07-31
LU84770A1 (fr)	1984-11-28

Publication	Publication Date	Title
DK470583D0 (da)	1983-10-12	Fremgangsmade til fremstilling af 1-phenyl-2-piperidinopropanolderivater
DK280182A (da)	1982-12-24	Fremgangsmaade til fremstilling af n-aryl-piperazinalkanamider
DK350083D0 (da)	1983-07-29	Fremgangsmade til fremstilling af phenylethanolaminer
DK492783D0 (da)	1983-10-27	Fremgangsmade til fremstilling af 3-aryl-5-pyrazol-derivater
DK95483D0 (da)	1983-02-25	Fremgangsmade til fremstilling af tetrahydropyranderivater
DK183583D0 (da)	1983-04-26	Fremgangsmade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner
DK210083D0 (da)	1983-05-11	Fremgangsmade til fremstilling af 6a,10a-trans-hexahydrodibenzopyranoner
DK299483A (da)	1984-01-30	Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK115581A (da)	1981-09-28	Fremgangsmaade til fremstilling af pyrimidylquinazoliner
DK370582A (da)	1983-02-20	Fremgangsmaade til fremstilling af 2-beta-d-ribofuranosylthiazol-4-carboxamid
DK283083A (da)	1983-12-23	Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK159309C (da)	1991-03-11	Fremgangsmaade til fremstilling af 4-metyl-5-alkylthiometyl-imidazoler
DK40883D0 (da)	1983-02-01	Fremgangsmade til fremstilling af benzothienylallylaminer
DK449881A (da)	1981-10-12	Fremgangsmaade til fremstilling af moroxydinphenoxyisobutyrater
DK361983A (da)	1984-02-10	Fremgangsmaade til fremstilling af meldroejealkaloider
DK394783D0 (da)	1983-08-30	Fremgangsmade til fremstilling af n-phosphonometylglycin
DK399783A (da)	1984-03-04	Fremgangsmaade til fremstilling af substituerede 1-pyridyloxy-3-indolylalkylamino-2-propanoler
DK518883A (da)	1984-05-17	Fremgangsmaade til fremstilling af 1-oxa-beta-lactam-forbindelser
DK457983D0 (da)	1983-10-04	Fremgangsmade til fremstilling af beta-lactam
DK385983D0 (da)	1983-08-23	Fremgangsmade til fremstilling af 1-oxacephamer
DK432683D0 (da)	1983-09-22	Fremgangsmade til fremstilling af 2-hydroxy-2-phenylethylaminer
DK156061C (da)	1989-11-06	Fremgangsmaade til fremstilling af 2-alkyl-4-amino-5-aminomethylpyrimidin
DK400481A (da)	1982-03-11	Fremgangsmaade til fremstilling af 4-carbamoyloxy-oxazaphosporiner
DK9383D0 (da)	1983-01-11	Fremgangsmade til fremstilling af phosphinoxider
DK179183A (da)	1983-10-24	Fremgangsmaade til fremstilling af hydroxymethylbutensyrer

Legal Events

Date	Code	Title	Description
1987-01-01	AHB	Application shelved due to non-payment